ProQR Therapeutics (PRQR) Receivables - Other (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Receivables - Other for 5 consecutive years, with $364345.6 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 59.17% to $364345.6 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $364345.6 through Dec 2025, down 59.17% year-over-year, with the annual reading at $364345.6 for FY2025, 59.17% down from the prior year.
  • Receivables - Other hit $364345.6 in Q4 2025 for ProQR Therapeutics, down from $892277.2 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $892277.2 in Q4 2024 to a low of $306584.2 in Q4 2021.
  • Historically, Receivables - Other has averaged $549475.0 across 5 years, with a median of $382592.8 in 2022.
  • Biggest five-year swings in Receivables - Other: surged 109.51% in 2023 and later plummeted 59.17% in 2025.
  • Year by year, Receivables - Other stood at $306584.2 in 2021, then rose by 24.79% to $382592.8 in 2022, then soared by 109.51% to $801575.2 in 2023, then increased by 11.32% to $892277.2 in 2024, then crashed by 59.17% to $364345.6 in 2025.
  • Business Quant data shows Receivables - Other for PRQR at $364345.6 in Q4 2025, $892277.2 in Q4 2024, and $801575.2 in Q4 2023.